915 nm Light-Triggered Photodynamic Therapy and MR/CT Dual-Modal Imaging of Tumor Based on the Nonstoichiometric Na0.52YbF3.52:Er Upconversion Nanoprobes
915 nm Light-Triggered Photodynamic Therapy and MR/CT Dual-Modal Imaging of Tumor Based on the Nonstoichiometric Na0.52YbF3.52:Er Upconversion Nanoprobes
复制标题
基于非化学计量 Na0.52YbF3.52:Er 上转换纳米探针的 915 nm 光触发光动力治疗和 MR/CT 双模态肿瘤成像
DOI:
10.1002/smll.201601023
复制
发表时间:
2016
期刊:
影响因子:
13.3
通讯作者:
Lin Hongzhen
中科院分区:
文献类型:
--
作者:
Huang Yanan;Xiao Qingbo;Hu Huishan;Zhang Kunchi;Feng Yamin;Li Fujin;Wang Jian;Ding Xianguang;Jiang Jiang;Li Yanfang;Shi Liyi;Lin Hongzhen
Lanthanide (Ln3+)‐doped upconversion nanoparticles (UCNPs) as a new generation of multimodal bioprobes have attracted great interest for theranostic purpose. Herein, red emitting nonstoichiometric Na0.52YbF3.52:Er UCNPs of high luminescence intensity and color purity are synthesized via a facile solvothermal method. The red UC emission from the present nanophosphors is three times more intense than the well‐known green emission from the ≈30 nm sized hexagonal‐phase NaYF4:Yb,Er UCNPs. By utilizing Na0.52YbF3.52:Er@SrF2UCNPs as multifunctional nanoplatforms, highly efficient in vitro and in vivo 915 nm light‐triggered photodynamic therapies are realized for the first time, with dramatically diminished overheating yet similar therapeutic effects in comparison to those triggered by 980 nm light. Moreover, by virtue of the high transverse relaxivity (r2) and the strong X‐ray attenuation ability of Yb3+ions, these UCNPs also demonstrate good performances as contrast agents for high contrast magnetic resonance and X‐ray computed tomography dual‐modal imaging. Our research shows the great potential of the red emitting Na0.52YbF3.52:Er UCNPs for multimodal imaging‐guided photodynamic therapy of tumors.